Wouter Deneyer advises life sciences and other innovative companies on R&D, commercial, and regulatory matters.
Being involved in R&D contracts on a daily basis, he is specialized in negotiations with universities, fee-for-service providers, and partners on strategic research collaborations and licensing.
Wouter has a particular expertise in international and domestic R&D collaborations and European and domestic funding schemes. He regularly advises on European collaboration projects under the Horizon2020 framework (including PPP initiatives such as the Innovative Medicines Initiative 2), on locally funded projects as well as on private collaborations between industry and academic players.

He also advises on commercial matters, such as supply chain, distribution, and promotion contracts.
Wouter regulatory expertise focusses on clinical trials, data protection, and public private partnership programmes under the EU’s Horizon 2020 framework.
Prior to starting Invigolaw in 2017, Wouter worked for the Life Sciences department of the Belgian law firm Quinz (2012 – 2017) and the Corporate M&A department of the US law firm Jones Day (2008 – 2012). Wouter also worked in-house at the headquarters of an EFPIA company in Germany.